TYK320: Difference between revisions
m 1 revision imported |
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK" |
||
| Line 29: | Line 29: | ||
<p style="text-align: center;">[[TYK319|<Prev Question]] --- [[TYK321|Next Question>]]</p> | <p style="text-align: center;">[[TYK319|<Prev Question]] --- [[TYK321|Next Question>]]</p> | ||
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | <p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | ||
[[Category:TYK]] | |||
Latest revision as of 02:34, 25 September 2026
Children presenting with pheochromocytoma should be tested for:
a) von Hipple-Lindau disease
b) Neurofibromatosis type 1
c) Multiple endocrine neoplasia, type 2
d) Succinate dehydrogenase mutations
e) All of the above
Click for Answer
Answer
Answer e. 40% of pheochromocytomas in children are associated with these genetic conditions. All young patients (under 50) should be offered genetic screening, especially as the succinate dehydrogenase mutations are associated with a high risk of malignancy.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.